The Impact of Nursing and Pharmacy Care Between Xeloda and 5-Fluoruracil Regimens in the Management of Colorectal Cancer (CRC) in Hong Kong

Trial Profile

The Impact of Nursing and Pharmacy Care Between Xeloda and 5-Fluoruracil Regimens in the Management of Colorectal Cancer (CRC) in Hong Kong

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Capecitabine (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2017 Status changed from recruiting to discontinued.
    • 11 Feb 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Aug 2013 to 1 Dec 2014.
    • 06 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top